The pharma solution Plot no 73 , industrial area, phase 2 , Chandigarh 160002

Kidney Transplant Medicines

Megagraftin 0.5 MG

Tacrolimus Capsules I.P

Tacrolimus is a macrolide lactone with potent immunosuppressive activity, isolated from Streptomyces tsukubaensis. Tacrolimus is a macrolide immunosuppressant produced by Streptomyces tsukubaensis. Tacrolimus has an empirical formula of C44H69NO12, H2O and a formula weight of 822.05.

Megagraftin 1 MG

Tacrolimus Capsules I.P

Tacrolimus is a macrolide lactone with potent immunosuppressive activity, isolated from Streptomyces tsukubaensis. Tacrolimus is a macrolide immunosuppressant produced by Streptomyces tsukubaensis. Tacrolimus has an empirical formula of C44H69NO12, H2O and a formula weight of 822.05.

Megagraftin 2 MG

Tacrolimus Capsules I.P

Tacrolimus is a macrolide lactone with potent immunosuppressive activity, isolated from Streptomyces tsukubaensis. Tacrolimus is a macrolide immunosuppressant produced by Streptomyces tsukubaensis. Tacrolimus has an empirical formula of C44H69NO12, H2O and a formula weight of 822.05.

Norjectin 500 MG

Mycophenolate Mofetil Tablets I.P

NORJECTIN 500 MG is mycophenolate mofetil, which is chemically the 2- morpholinoethyl ester of mycophenolic acid (MPA), an immunosuppressive agent; inosine monophosphate dehydrogenase (IMPDH) inhibitor.

Norjectin-S 360 MG

Mycophenolic Acid Delayed-Release Tablets U.S.P. 360 MG

Norjectin S 360 is an enteric formulation of Mycophenolate sodium that delivers the active moiety Mycophenolic acid (MPA). NORJECTIN S 360 is an immunosuppressant agent. MPA is chemically designated as(E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydroisobenzofuran-5-yl)-4-methylhex-4-enoic acid sodium salt. Its empirical formula is C17H19O6 Na and molecular weight is 342.32.

Brilcyto 450 mg

Valganciclovir hydrochloride (C14H22N6O4.Hcl; MWt=390.83) is the Hcl salt of the L-valyl ester of Ganciclovir, which is a synthetic 2′-deoxy-guanosine analogue used for the prevention and treatment of cytomegalovirus (CMV) infections in immunocompromised or immunosuppressed patients. Valganciclovir is the pro-drug for Ganciclovir. After oral administration, it is rapidly converted to Ganciclovir by intestinal and hepatic esterases.